Clover Therapeutics discovers and develops precision medicines for diseases of aging with a genetics-driven approach. We have a genetically diverse, longitudinal, and re-contactable Medicare patient network with comprehensive clinical data as the foundation of our clinico-genomic studies. We are currently advancing preclinical drug programs in Age-related Macular Degeneration (AMD), and conducting two observational clinical studies in this disease.
Investors 3
Date | Name | Website |
- | MBC BioLab... | mbcbiolabs... |
20.07.2021 | Lifeforce ... | lifeforcec... |
11.08.2020 | Cantos Ven... | cantos.vc |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
10.07.2019 | Medicare A... | The two organizations will wor... | - | - | medcitynew... |
- | Medicare A... | Medicare Advantage startup Clo... | - | - | medcitynew... |